Pfizer: Keep On Riding The Recovery

Summary:

  • Pfizer investors are enjoying their recent run as PFE stock has outperformed its peers and the market.
  • Palpable optimism is reflected in PFE’s upcoming Q2 earnings release.
  • Investors have likely moved on from its COVID vaccine franchise into its oncology and weight-loss drugs growth prospects.
  • PFE’s attractive valuation and solid dividend yield suggest the recovery is likely far from over.
  • I argue why pessimism on PFE didn’t pay off for the bearish investors. Investors should keep riding on its recovery.

Pfizer

no_limit_pictures

Pfizer: Worst Likely Over

With palpable optimism, Pfizer (NYSE:PFE) investors are likely looking forward to the pharmaceutical leader’s upcoming earnings release. PFE delivered a disappointing 1Y total return of -11.5%, significantly underperforming the S&P 500 (


Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.


A Unique Price Action-based Growth Investing Service

  • We believe price action is a leading indicator. 
  • We called the TSLA top in late 2021.
  • We then picked TSLA’s bottom in December 2022.
  • We updated members that the NASDAQ had long-term bearish price action signals in November 2021.
  • We told members that the S&P 500 likely bottomed in October 2022.
  • Members navigated the turning points of the market confidently in our service.
  • Members tuned out the noise in the financial media and focused on what really matters: Price Action.

Sign up now for a Risk-Free 14-Day free trial!

Leave a Reply

Your email address will not be published. Required fields are marked *